480 High-Flow Ultrafiltration Control Dialysate
510(k) K880459
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK880459 | Date13 Apr 1988 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- FKP
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.5820
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
This device is a System, Dialysate Delivery, Single Patient, designed for high-flow ultrafiltration control in dialysis therapy. It regulates and monitors dialysate flow, temperature, conductivity, and pressure to ensure precise ultrafiltration during hemodialysis procedures, supporting renal replacement therapy for patients with acute or chronic kidney failure.
The 480 High-Flow Ultrafiltration Control Dialysate is supplied as part of a single-patient-use dialysate delivery system, intended for use in clinical settings such as dialysis centers. It is classified as a Class II device under FDA regulations (21 CFR 876.5820) and holds a FDA 510(k) clearance (K880459) with a decision date of April 13, 1988. The system is not explicitly described as sterile or reusable in the provided data, though its single-patient-use designation implies disposable components.
Other devices from Cd Medical, Inc.
Questions
AI-generated answers, 19 Sep 2026
What specific clinical applications does the 480 High-Flow Ultrafiltration Control Dialysate support during dialysis therapy?
This device is designed to regulate and monitor critical parameters—such as dialysate flow, temperature, conductivity, and pressure—during hemodialysis. It ensures precise ultrafiltration control, which is essential for managing fluid removal in patients with acute or chronic kidney failure. The system is specifically part of a single-patient-use dialysate delivery system, making it suitable for renal replacement therapy in clinical settings like dialysis centers.
Is the 480 High-Flow Ultrafiltration Control Dialysate intended for reuse, or is it meant for single-patient use?
The device is explicitly labeled as a single-patient-use dialysate delivery system, meaning it is not designed for reuse. While the data does not explicitly state sterility, the single-patient-use designation implies that disposable components are intended for one-time use per patient to maintain safety and hygiene standards.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its use?
The 480 High-Flow Ultrafiltration Control Dialysate received FDA 510(k) clearance (K880459) under the Traditional 510(k) review pathway, with a decision date of April 13, 1988. This means the manufacturer demonstrated that their device is substantially equivalent to a legally marketed predicate device, allowing it to enter the market without requiring a new clinical trial. Clinically, this clearance confirms the device meets FDA safety and effectiveness standards for its intended use in hemodialysis.
How is the device classified under FDA regulations, and what does that classification imply for its oversight?
This device is classified as a Class II medical device under 21 CFR 876.5820, which means it is subject to special controls—such as performance standards, labeling requirements, and post-market surveillance—to ensure its safety and effectiveness. While Class II devices generally pose moderate risk, the FDA imposes additional scrutiny compared to Class I devices, ensuring rigorous validation of its performance in ultrafiltration control during dialysis.